GDPR Considerations for DtP Supply Chains
Regulatory, Supply Chain
One of the primary challenges with Direct-to-Patient (DtP) supply chains is maintaining patient privacy. This is further complicated by the GDPR (General Data Protection Regulation), which is broadly designed to protect the right to personal data privacy for all EU citizens. The GCSG DTP Sub-team provides an overview of the key GDPR considerations and recommendations for organizations engaged in DtP.
Related Education Resources.
All ResourcesCOVID-19 and the Clinical Supply Chain: Mitigating Risk and Maintaining Business Continuity
Topics: COVID-19, Pharma Industry, Supply Chain
Position Paper
Free
Recent Developments in the Global Regulatory Landscape
Topic: Regulatory
Webinar
Free
Commercialization of Personalized Medicines
Topic: Pharma Industry
Report
Members
